C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2011
12/01/2011	US20110296548 Hybrids of, and Cultivars Derived From the Rice Cultivar Designated 'CL151'
12/01/2011	US20110296547 Modifying the dna recombination potential in eukaryotes
12/01/2011	US20110296546 Human CTLA-4 Antibodies And Their Uses
12/01/2011	US20110296545 Compositions and methods for treating or preventing conditions and diseases associated with mannheimia haemolytica
12/01/2011	US20110296544 Colon cancer targets and uses thereof
12/01/2011	US20110296541 Production of proteins in eggs
12/01/2011	US20110296539 Mutant Alpha-Synuclein, and Methods Using Same
12/01/2011	US20110296538 In vivo quantitative screening test for anti-metastasis treatment efficacy
12/01/2011	US20110294989 Processing of recombinant human g-csf
12/01/2011	US20110294984 Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity
12/01/2011	US20110294983 Single-chain antiparallel coiled coil proteins
12/01/2011	US20110294874 Diagnosis and therapy of organ dysfunction using sphinganine-1-phosphate
12/01/2011	US20110294873 Gene Transfer Vectors Comprising At Least One Isolated DNA Molecule Having Insulator Or Boundary Properties And Methods To Identify The Same
12/01/2011	US20110294871 Lipids, lipid complexes and use thereof
12/01/2011	US20110294870 Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
12/01/2011	US20110294869 Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating rna interference
12/01/2011	US20110294867 Sensizitation of cancer cells to therapy using sina targeting genes from the 1p and 19q chromosomal regions
12/01/2011	US20110294866 Pharmaceutical composition for treating dementia comprising shrna inhibiting s100a9 expression
12/01/2011	US20110294865 Methods of detecting a fragment of neurosecretory protein vgf for diagnosing alzheimer's disease
12/01/2011	US20110294827 Iap binding compounds
12/01/2011	US20110294790 Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
12/01/2011	US20110294761 Stem cell cultures
12/01/2011	US20110294753 Means and methods for counteracting muscle disorders
12/01/2011	US20110294752 Triterpene compositions and methods for use thereof
12/01/2011	US20110294748 Insulin-like growth factor 1 receptor binding peptides
12/01/2011	US20110294741 Use of compounds in the treatment of tau-induced cytotoxicities
12/01/2011	US20110294737 Terminally-differentiated anucleate platelet progeny generation
12/01/2011	US20110294733 Modified human thrombopoietin polypeptide fragment and manufacturing method thereof
12/01/2011	US20110294697 System for detectng protease
12/01/2011	US20110294678 Cells screening method
12/01/2011	US20110294226 Survival motor Neurons (SMN) gene: a gene for spinal muscular atrophy
12/01/2011	US20110294216 Sulfonylurea-responsive repressor proteins
12/01/2011	US20110294215 Culture systems
12/01/2011	US20110294214 Seeding Cells on Porous Supports
12/01/2011	US20110294213 2'-arabino-fluorooligonucleotide n3'-p5' phosphoramidates: their synthesis and use
12/01/2011	US20110294212 Methods of Screening Molecular Libraries and Active Molecules Identified Thereby
12/01/2011	US20110294211 Hepatocyte lineage cells
12/01/2011	US20110294210 Microcarriers for Stem Cell Culture
12/01/2011	US20110294209 Methods for producing nonadherent avian cell lines
12/01/2011	US20110294208 Method and device for cell selection and collection in an isolated culturing environment
12/01/2011	US20110294207 Spatially-defined modification of fresh tissue using covalent chemistry
12/01/2011	US20110294206 Methods and design of membrane filters
12/01/2011	US20110294205 Automated cellular material preparation
12/01/2011	US20110294195 EFFICIENT CELL CULTURE SYSTEM FOR HEPATITIS C VIRUS GENOTYPE 7a
12/01/2011	US20110294194 Efficient cell culture system for hepatitis c virus genotype 2b
12/01/2011	US20110294190 Mutant human superoxide dismutase 1 variants
12/01/2011	US20110294188 Ideotypically Modulated Pharmacoeffectors For Selective Cell Treatment
12/01/2011	US20110294182 Botryoccocus braunii Triterpene Synthase Proteins and Nucleic Acid Molecules, and Methods for Their Use
12/01/2011	US20110294166 Thermostable enzymes for the hydrolysis of mannan-containing polysaccharides
12/01/2011	US20110294162 B-7 related nucleic acids and polypeptides useful for immunomodulation
12/01/2011	US20110294156 Novel anti cxcr4 antibodies and their use for the treatment of cancer
12/01/2011	US20110294149 Alzheimer's Disease Secretase, APP Substrates Therefor, and Uses Therefor
12/01/2011	US20110294146 Identification of Actinobacillus actinomycetemcomitans Antigens for Use in the Diagnosis, Treatment, and Monitoring of Periodontal Diseases
12/01/2011	US20110294145 Reagents and methods for detecting a polymorphic protein
12/01/2011	US20110294127 Elite event a2704-12 and methods and kits for identifying such event in biological samples
12/01/2011	US20110293815 Corn plants and seed enhanced for asparagine and protein
12/01/2011	US20110293810 White wheat varieties, and compositions and methods of using the same
12/01/2011	US20110293707 Use of the cathelicidin ll-37 and derivatives thereof for wound healing
12/01/2011	US20110293705 Methods and compositions for localized agent delivery
12/01/2011	US20110293704 Priming of an immune response
12/01/2011	US20110293698 Reagents and Methods for Treating Cancer
12/01/2011	US20110293666 Bioengineered Tissue Constructs and Methods for Production and Use
12/01/2011	US20110293656 Recombinant mva capable of expressing structural hcv antigens
12/01/2011	US20110293653 Antagonists of mir-155 for the treatment of inflammatory liver disease
12/01/2011	US20110293646 PAN-DR Binding Polypeptides and Uses Thereof
12/01/2011	US20110293645 Wdrpuh epitope peptides and vaccines containing the same
12/01/2011	US20110293644 Compositions and methods for treatment of celiac disease
12/01/2011	US20110293639 Ideotypically modulated pharmacoeffectors for selective cell treatment
12/01/2011	US20110293635 Composition and methods for modulating toll-like receptor activity
12/01/2011	US20110293632 Polypeptide variants with altered effector function
12/01/2011	US20110293625 Inhibition of vegf-a secretion, angiogenesis and/or neoangiogenesis by sina mediated knockdown of vegf-c and rhoa
12/01/2011	US20110293619 CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
12/01/2011	US20110293618 Anti-human clcp1 antibody and use thereof
12/01/2011	US20110293617 Anti-p-selectin antibodies and methods of their use and identification
12/01/2011	US20110293614 Isoform specific anti-her4 antibodies
12/01/2011	US20110293613 Bispecific antibodies
12/01/2011	US20110293610 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
12/01/2011	US20110293609 Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
12/01/2011	US20110293601 Composition and method for treatment of reperfusion injury and tissue damage
12/01/2011	US20110293599 Method for modulating muscle differentiation or regeneration
12/01/2011	US20110293593 Siva 2 stabilization
12/01/2011	US20110293587 Glucagon analogues
12/01/2011	US20110293586 Glucagon analogues
12/01/2011	US20110293583 Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
12/01/2011	US20110293580 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
12/01/2011	US20110293578 Use of Stem Cells to Prevent Neuronal Dieback
12/01/2011	US20110293577 Therapeutic Methods Using Adipose Tissue-Derived Cell Suspensions Comprising Adipocytes
12/01/2011	US20110293576 Mesenchymal stromal cell populations and methods of isolating and using same
12/01/2011	US20110293575 Photochemical internalisation of kinase inhibitors
12/01/2011	US20110293574 Hematopoietic stem cell growth factor
12/01/2011	US20110293573 Method and apparatus for culturing tissue
12/01/2011	US20110293572 Increasing the plasticity of stem cells
12/01/2011	US20110293557 Conjugates for the administration of biologically active compounds
12/01/2011	US20110293526 Compositions and methods to modulate hair growth
12/01/2011	US20110293525 Tumor stem cells
12/01/2011	US20110293524 Methods and compositions for the regulation of lectin complement pathway (lcp)-associated complement activation in hyperglycemic myocardial damage
12/01/2011	CA2837011A1 Brassica plants yielding oils with a low alpha linolenic acid content
12/01/2011	CA2804119A1 Induced malignant stem cells or pre-induction cancer stem cells capable of self-replication outside of an organism, production method for same, and practical application for same
12/01/2011	CA2800731A1 Compositions and methods of using living and non-living bioactive devices with components derived from self-renewing colony forming cells cultured and expanded in vitro
12/01/2011	CA2800728A1 Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase

1 ... 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 ... 1827